• Dasatinib (BMS-354825) Research Workflow

  2026-09-17

  Build a context-first workflow for connecting Dasatinib-mediated Src and Bcr-Abl inhibition with phosphorylation, cell-cycle, EMT, and metastatic phenotypes. This guide separates evidence-backed use cases from hypothesis-generating applications in prostate, pancreatic, leukemia, and thymic tumor research.

• HyperPFU™ high-fidelity DNA polymerase Guide

  2026-09-17

  HyperPFU™ high-fidelity DNA polymerase is intended for accurate PCR amplification of long, GC-rich, inhibited, or otherwise difficult DNA templates. It produces blunt-ended amplicons, so it is suitable for accuracy-focused cloning and sequencing workflows but not for protocols that require 3′-A overhangs or preformed sticky ends.

• SNAI1–PIK3R2/p-EphA2 Signaling in Thymic Tumors

  2026-09-16

  This 2024 study identifies SNAI1 as an oncogenic hub in thymic epithelial tumors and links it to epithelial–mesenchymal transition, cancer stem cell-like traits, and macrophage-state remodeling. Through integrated transcriptomic, epigenomic, proteomic, and functional assays, the authors define a SNAI1–PIK3R2/p-EphA2–GSK3β/β-catenin signaling axis that may inform therapeutic research in thymic carcinoma.

• Dasatinib Monohydrate for Reliable Cell Assays

  2026-09-16

  Learn how Dasatinib Monohydrate, SKU B5954, can support more interpretable viability, proliferation, and cytotoxicity experiments in kinase-driven models. This scenario-based guide covers formulation, controls, dose design, resistance studies, and practical product-selection criteria.

• NETs in CML: TKI Effects and Vascular Risk

  2026-09-15

  The reference study shows that neutrophil extracellular trap formation is elevated in chronic myeloid leukemia and is differentially altered by tyrosine kinase inhibitors. Its combination of patient-derived neutrophils with a BCR-ABL1-transduced differentiation model provides a mechanistic framework for studying how leukemia biology and TKI-associated vascular risk may intersect.

• KLF4, ERK, and AgRP Isoform Control in Mice

  2026-09-15

  The reference study shows that KLF4 directly promotes Agrp transcription in mouse Agrp-expressing cells, while the relative contribution of this mechanism depends on tissue, metabolic state, and ERK activity. Its isoform-resolved design distinguishes regulation in the hypothalamic arcuate nucleus from expression in placenta and provides a framework for interpreting how obesity reshapes energy-balance gene control.

• 2,2,2-Trichloroethanol Protein Workflows

  2026-09-14

  2,2,2-Trichloroethanol is a practical small molecule biochemical for rapid protein visualization and workflow checks in electrophoresis. This guide connects its use as a protein analysis reagent with translational neuroscience assays while clearly separating established protein applications from exploratory cross-domain applications.

• Ang II–HIF-1α–HILPDA Axis in NPC Radioresistance

  2026-09-14

  This study identifies a local angiotensin II–AGT–HIF-1α–HILPDA circuit that suppresses ferroptosis and promotes radioresistance in nasopharyngeal carcinoma. Its combination of molecular, cellular, animal, and tissue analyses supports dual targeting of angiotensin signaling and ferroptosis as a strategy for improving radiotherapy response, while also highlighting candidate biomarkers for patient stratification.

• TBXA2R–ERM Signaling in TNBC Metastasis

  2026-09-13

  The reference study identifies TBXA2R as an upstream GPCR activator of ezrin, radixin, and moesin, connecting G-protein signaling to cytoskeletal remodeling, motility, invasion, and metastatic colonization in triple-negative breast cancer. Its main practical contribution is a receptor-to-ERM framework that can guide mechanistic experiments on metastatic behavior while highlighting the need to distinguish migration phenotypes from complete metastatic progression.

• Aconitase Activity Colorimetric Assay Kit Guide

  2026-09-12

  Learn how to use the Aconitase Activity Colorimetric Assay Kit to connect TCA-cycle function, oxidative injury, and immune-cell metabolism. The workflow emphasizes practical controls, quantitative normalization, and complementary interpretation alongside the CD28-ARS2-PKM findings in activated CD8+ T cells.

• Limb Organoids Reveal How AER Signaling Organizes Fate

  2026-09-12

  The reference preprint introduces mouse embryonic stem cell-derived limb organoids, or budoids, that combine apical ectodermal ridge-like, surface ectoderm, mesodermal, and fibroblast-like properties. Its central finding is that AER-like cells do more than provide developmental signals: they coordinate local cell-fate support with tissue polarization, enabling cartilage formation at a distance.

• AP20187: Dimerization Control for Tumor-Stroma Studies

  2026-09-11

  AP20187 is a chemical inducer of dimerization that can provide temporal control over engineered signaling systems. This article develops a distinct assay strategy connecting conditional signaling to senescent cancer-associated fibroblast biology and immune suppression in breast tumors.

• Maridomycin Macrolide Activity: In Vitro and In Vivo

  2026-09-11

  The reference study established maridomycin as a broad-acting macrolide antibiotic with strong activity against many Gram-positive organisms and selected Gram-negative pathogens. By combining susceptibility testing, resistance experiments, bactericidal measurements, protein-binding analysis, and mouse infection models, it connected in vitro behavior with therapeutic activity while identifying important limitations related to cross-resistance.

• 5-(N,N-dimethyl)-Amiloride: NHE1 Assay Guide

  2026-09-10

  Use 5-(N,N-dimethyl)-Amiloride hydrochloride to separate Na+/H+ exchanger-dependent pH and sodium transport from downstream endothelial, cardiac, and hepatic phenotypes. This workflow combines isoform-aware concentration design with direct pH, sodium, permeability, and signaling readouts for more defensible mechanism studies.

• Serine/Glycine-Free Diet, Immunity, and PD-L1 Lactylation

  2026-09-10

  A 2024 Cell Metabolism study shows that serine/glycine restriction can inhibit colorectal cancer growth and increase cytotoxic T-cell accumulation, while also enabling immune escape through PD-L1 lactylation. Its preclinical findings and single-arm phase I feasibility data support further evaluation of diet–immunotherapy combinations, but randomized validation and mechanistic refinement remain necessary.

7946 records 1/530 page Next 12345 下5页 Last page